cifox 2 mg/ml solution for infusion
rowex ltd - ciprofloxacin hydrochloride - solution for infusion - 2 mg/ml
linezolid 2mg/ml solution for infusion
infomed fluids - linezolid - solution for infusion - 2mg/ml - other antibacterials - it is indicated in adults for the treatment of community acquired pneumonia and nosocomial pneumonia when known or suspected to be caused by susceptible gram-positive bacteria. in determining whether linezolid 2 mg/ml solution for infusion is an appropriate treatment, the results of microbiological tests or information on the prevalence of resistance to antibacterial agents among grampositive bacteria should be taken into consideration. (see section 5.1 for the appropriate organisms).
ciprofloxacin alkaloid concentrate for solution for infusion
alkaloid ad skopje - ciprofloxacin - concentrate for solution for infusion - 10mg/ml
marion powder for solution for injection/infusion
anfarm hellas s.a. - ceftriaxone (ceftriaxone sodium) - powder for solution for injection/infusion - 1000mg
zyvoxid i.v. 2 mgml
pfizer pfe pharmaceuticals israel ltd - linezolid - solution for infusion - linezolid 2 mg/ml - linezolid - linezolid - therapy is indicated only when an organism resistant to all other antibiotics is suspected. zyvoxid is indicated in adult and pediatric patients for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: 1) pneumonia - community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (mdrsp). 2) skin and soft tissue infections including diabetic foot infections. 3) enterococcal infections. combination therapy may be indicated if a concomitant gram negative pathogen is documented or suspected.
marion powder and solvent for solution for i/m injection
anfarm hellas s.a. - ceftriaxone (ceftriaxone sodium) - powder and solvent for solution for i/m injection - 1000mg
vancomycin actavis 1000 mg pulver till koncentrat till infusionsvätska, lösning
cubicin 500 mg
merck sharp & dohme (israel - 1996) company ltd, israel - daptomycin - lyophilized powder for solution for injection - daptomycin 500 mg/vial - daptomycin - cubicin is indicated for the treatment of the infections listed below. * complicated skin and skin structure infectionscomplicated skin and skin structure infections (csssi) caused by susceptible isolates of the following gram-positive bacteria: staphylococcus aureus (including methicillin-resistant isolates), streptococcus pyogenes, streptococcus agalactiae, streptococcus dysgalactiae subsp. equisimilis, and enterococcus faecalis (vancomycin-susceptible isolates only).* staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolatesstaphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates.* combination therapy may be clinically indicated if the documented or presumed pathogens include gram negative or anaerobic organisms
tilcosin 250 oral solution
life biopharma sdn. bhd. - tilmicosin phosphate -
pivodine solution- povidone iodine solution
mwi/vet one - povidone-iodine (unii: 85h0hzu99m) (iodine - unii:9679tc07x4) - microbicide solution non-irritating, non-staining kills gram-negative and grampositive bacteria, fungi, viruses, protozoa and yeasts. film-forming, virtually non-irritating and non-staining to skin, hair and natural fabrics.